Serum levels of anti-hepatitis B surface antibodies among vaccinated children aged 1 to 12 years in a rural community in Fars Province, southern Iran

References

• Yuen, M. F.; Chen, D. S.; Dusheiko, G. M.; Janssen, H. L. A.; Lau, D. T. Y.; Locarnini, S. A.; Peters, M. G.; Lai, C. L. Hepatitis B Virus Infection. Nat. Rev. Dis. Primers. 2018, 4, 18035. DOI: 10.1038/nrdp.2018.35.
   PubMed Web of Science ®Google Scholar
• Tang, L. S. Y.; Covert, E.; Wilson, E.; Kottilil, S. Chronic Hepatitis B Infection: A Review. Jama 2018, 319(17), 1802–1813. DOI: 10.1001/jama.2018.3795.
   PubMed Web of Science ®Google Scholar
• Schweitzer, A.; Horn, J.; Mikolajczyk, R. T.; Krause, G.; Ott, J. J. Estimations of Worldwide Prevalence of Chronic Hepatitis B Virus Infection: A Systematic Review of Data Published between 1965 and 2013. Lancet 2015, 386(10003), 1546–1555. DOI: 10.1016/S0140-6736(15)61412-X.
   PubMed Web of Science ®Google Scholar
• Salehi-Vaziri, M.; Sadeghi, F.; Almasi Hashiani, A.; Gholami Fesharaki, M.; Alavian, S. M. Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis. Hepat. Mon. 2016, 16(4), e35577. DOI: 10.5812/hepatmon.
   PubMed Web of Science ®Google Scholar
• Almasi-Hashiani, A.; Ayubi, E.; Mansori, K.; Salehi-Vaziri, M.; Moradi, Y.; Gholamaliei, B.; Khazaei, S. Prevalence of Hepatitis B Virus Infection among Iranian High Risk Groups: A Systematic Review and Meta-analysis. Gastroenterol Hepatol. Bed Bench. 2018, 11(2), 91–100.
   PubMedGoogle Scholar
• Badfar, G.; Shohani, M.; Nasirkandy, M. P.; Mansouri, A.; Abangah, G.; Rahmati, S.; Aazami, S.; Soleymani, A.; Azami, M. Epidemiology of Hepatitis B in Pregnant Iranian Women: A Systematic Review and Meta-analysis. Arch. Virol. 2018, 163(2), 319–330. DOI: 10.1007/s00705-017-3551-6.
   PubMed Web of Science ®Google Scholar
• Khosravani, A.; Sarkari, B.; Negahban, H.; Sharifi, A.; Toori, M. A.; Eilami, O. Hepatitis B Infection among High Risk Population: A Seroepidemiological Survey in Southwest of Iran. BMC Infect. Dis. 2012, 12, 378. DOI: 10.1186/1471-2334-12-166.
   PubMed Web of Science ®Google Scholar
• Jafarzadeh, A.; Montazerifar, S. J. Persistence of anti-HBs Antibody and Immunological Memory in Children Vaccinated with Hepatitis B Vaccine at Birth. J. Ayub. Med. Coll. Abbottabad. 2006, 18(4), 4–9.
   PubMedGoogle Scholar
• Azarkar, Z.; Ebrahimzadeh, A.; Sharifzadeh, G.; Ziaee, M.; Fereidouni, M.; Taheri, F. Persistence of Immunity to Hepatitis B Vaccine as Infants, 17 Years Earlier. Caspian J. Intern. Med. 2018, 9(2), 184–188. DOI: 10.22088/cjim.9.2.184.
   PubMed Web of Science ®Google Scholar
• Kazemi, A.; Koosha, A.; Rafizadeh, B.; Mousavinasab, N.; Mahram, M. Serum Level of Anti-Hepatitis B Surface Antigen 6-8 Years after Hepatitis B Vaccination at Birth. East. Mediterr. Health J. 2008, 14(4), 960–965.
   PubMedGoogle Scholar
• Rezaei, M.; Nooripoor, S.; Ghorbani, R.; Ramezanshams, F.; Mamishi, S.; Mahmoudi, S. Seroprotection after Hepatitis B Vaccination in Children Aged 1 to 15 Years in Central Province of Iran, Semnan. J. Prev. Med. Hyg. 2014, 55(1), 1–3.
   PubMedGoogle Scholar
• Norouzirad, R.; Shakurnia, A. H.; Assarehzadegan, M. A.; Serajian, A.; Khabazkhoob, M. Serum Levels of Anti-hepatitis B Surface Antibody among Vaccinated Population Aged 1 to 18 Years in Ahvaz City Southwest of Iran. Hepat. Mon. 2014, 14(1), e13625. DOI: 10.5812/hepatmon.13625.
   PubMed Web of Science ®Google Scholar
• Bagheri-Jamebozorgi, M.; Keshavarz, J.; Nemati, M.; Mohammadi-Hossainabad, S.; Rezayati, M.-T.; Nejad-Ghaderi, M.; Jamalizadeh, A.; Shokri, F.; Jafarzadeh, A. The Persistence of anti-HBs Antibody and Anamnestic Response 20 Years after Primary Vaccination with Recombinant Hepatitis B Vaccine at Infancy. Hum. Vaccin. Immunother. 2014, 10(12), 3731–3736. DOI: 10.4161/hv.34393.
   PubMed Web of Science ®Google Scholar
• Gilca, V.; De Serres, G.; Boulianne, N.; Murphy, D.; De Wals, P.; Ouakki, M.; Trudeau, G.; Masse, R.; Dionne, M. Antibody Persistence and the Effect of a Booster Dose Given 5, 10 or 15 Years after Vaccinating Preadolescents with a Recombinant Hepatitis B Vaccine. Vaccine 2013, 31(3), 448–451. DOI: 10.1016/j.vaccine.2012.11.037.
   PubMed Web of Science ®Google Scholar
• Zanetti, A. R.; Mariano, A.; Romano, L.; D’Amelio, R.; Chironna, M.; Coppola, R. C.; Cuccia, M.; Mangione, R.; Marrone, F.; Negrone, F. S.; et al. Long-term Immunogenicity of Hepatitis B Vaccination and Policy for Booster: An Italian Multicentre Study. Lancet 2005, 366(9494), 1379–1384. DOI: 10.1016/S0140-6736(05)67568-X.
   PubMed Web of Science ®Google Scholar
• Karatekin, G.; Kilinc, M.; Gulcan Oksuz, B.; Igde, M. Hepatitis B Seroprevalence in Children and Women and the Impact of the Hepatitis B Vaccination Program in the Black Sea Region of Turkey. J. Infect. Dev. Ctries. 2013, 7(12), 960–965. DOI: 10.3855/jidc.4102.
   PubMed Web of Science ®Google Scholar
• Shamsizadeh, A.; Makvandi, M.; Shoshtari, G. Prevalence of Anti Hepatitis B Surface Antibody among Children in Ahvaz, Iran, Five Years after Vaccination. Jundishapur J. Microbiol. 2011, 4(1), 49–54.
   Web of Science ®Google Scholar
• Esteghamati, A.; Keshtkar, A. A.; Nadjafi, L.; Gouya, M. M.; Salaramoli, M.; Roshandel, G.; Yaghini, F. Hepatitis B Vaccination Coverage among Iranian Children Aged 15-26 months in 2006. East. Mediterr. Health J. 2011, 17(2), 93–100.
   PubMedGoogle Scholar